ED Cervical Cancer Screening Intervention Detects Abnormal Findings at Three Times the National Rate
Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at ...
The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...
It is recommended that women between 30 and 65 undergo co-testing with Human papillomavirus (HPV) and Pap smear testing every five years or Pap testing alone every three years.
Our editors independently select these products. Making a purchase through our links may earn Well+Good a commission Like most women, I don’t exactly look forward to gyno appointments. It’s nothing ...
Women who get a full dose of the human papillomavirus (HPV) vaccine may only need two cervical cancer screenings in their ...
Histological detection, or microscopic examination of tissue samples, of cancer was comparable between self- and ...
Looking for signs of the cancer in a more convenient way could help women access the test and prevent the disease occurring, ...
Cervical cancer is a prevalent yet most misrepresented health risk among women currently that is very avoidable. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results